<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="157039-2018"
            EDITION="2018071">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-161261-001</RECEPTION_ID>
      <DELETION_DATE>20180719</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>71</NO_OJ>
         <DATE_PUB>20180412</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 071-157039</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:157039-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="UK"/>
         <IA_URL_GENERAL>https://nhsengland.bravosolution.co.uk</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33690000">Various medicinal products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="UK">UNITED KINGDOM</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="UK">UNITED KINGDOM</n2016:CA_CE_NUTS>
         <n2016:TENDERER_NUTS CODE="UK">UNITED KINGDOM</n2016:TENDERER_NUTS>
         <VALUES>
            <VALUE TYPE="PROCUREMENT_TOTAL" CURRENCY="GBP">434000000.00</VALUE>
         </VALUES>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 188-384724</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180410</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="1">Ministry or any other national or federal authority</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Обединено кралство</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Spojené království/Velká Británie</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Forenede Kongerige, Det</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>das Vereinigte Königreich</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ηνωμένο Βασίλειο</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>United Kingdom</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Suurbritannia / Ühendkuningriik</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Yhdistynyt kuningaskunta</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Royaume-Uni</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ríocht Aontaithe, an</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Ujedinjena Kraljevina</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Egyesült Királyság</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Regno Unito</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Jungtinė Karalystė, Didžioji Britanija</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Apvienotā Karaliste</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>Ir-Renju Unit</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Verenigd Koninkrijk</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Zjednoczone Królestwo</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Reino Unido</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Regatul Unit</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Spojené kráľovstvo</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Združeno kraljestvo</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Förenade kungariket</TI_CY>
            <TI_TOWN>Runcorn</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">The NHS Commissioning Board (Operating Under the Name of NHS England)</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>The NHS Commissioning Board (Operating Under the Name of NHS England)</OFFICIALNAME>
               <ADDRESS>2nd Floor, Rutland House</ADDRESS>
               <TOWN>Runcorn</TOWN>
               <POSTAL_CODE>WA7 2ES</POSTAL_CODE>
               <COUNTRY VALUE="UK"/>
               <PHONE>+44 1928755227</PHONE>
               <E_MAIL>gemma.tomlinson1@nhs.net</E_MAIL>
               <n2016:NUTS CODE="UK"/>
               <URL_GENERAL>https://nhsengland.bravosolution.co.uk</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="MINISTRY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>NHS National Generic Pharmaceuticals — Wave 11</P>
            </TITLE>
            <REFERENCE_NUMBER>CM/PHG/17/5530</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Invitation to offer for NHS National Generic Pharmaceuticals — Wave 11.</P>
               <P>Offer reference number: CM/PHG/17/5530.</P>
               <P>Period of Framework Agreement: Dates detailed below with options to extend up to a maximum period of 26 months.</P>
               <P>Potential periods of call-offs under the Framework Agreement: Hospital Only Products — Central and South West (CESW) 1.7.2018 to 31.7.2019 (13 months); North West and Eastern and North London (NWLN) 1.7.2018 to 31.7.2019 (13 months) and South East and South London and North East and Yorkshire (LSNE) 1.7.2018 to 31.7.2019 (13 months).</P>
               <P>Oral Products — All Regions 1.7.2018 to 28.2.2019 (8 months).</P>
            </SHORT_DESCR>
            <VAL_TOTAL CURRENCY="GBP">434000000.00</VAL_TOTAL>
            <LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <TITLE>
                  <P>Wave 11 — Oral Products: All regions</P>
               </TITLE>
               <LOT_NO>01</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <MAIN_SITE>
                  <P>Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>NHS National Generic Pharmaceuticals — Wave 11.</P>
                  <P>Offer Reference Number: CM/PHG/17/5530.</P>
                  <P>Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 26 months.</P>
                  <P>Potential period of call-off under the Framework Agreement: Oral Products: All Regions 1.7.2018 to 28.02.2019 (8 months).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Price is not the only award criterion and all criteria are stated only in the procurement documents</AC_CRITERION>
                  <AC_WEIGHTING>In descending order</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>The Most Economically Advantageous Tender in terms of the criteria stated in the specification, in the Invitation to Tender or to negotiate or in the descriptive document</AC_CRITERION>
                  <AC_WEIGHTING>N/A</AC_WEIGHTING>
               </AC_COST>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>This Framework Agreement has the option to extend for a period of up to 8 months.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="2">
               <TITLE>
                  <P>Wave 11 — Hospital Only Products: CESW</P>
               </TITLE>
               <LOT_NO>02</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <MAIN_SITE>
                  <P>Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>NHS National Generic Pharmaceuticals — Wave 11.</P>
                  <P>Offer Reference Number: CM/PHG/17/5530.</P>
                  <P>Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 26 months.</P>
                  <P>Potential period of call-off under the Framework Agreement: Hospital Only Products:</P>
                  <P>CESW 1.7.2018 to 31.7.2019 (13 months).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Price is not the only award criterion and all criteria are stated only in the procurement documents</AC_CRITERION>
                  <AC_WEIGHTING>In descending order</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>The Most Economically Advantageous Tender in terms of the criteria stated in the specification, in the Invitation to Tender or to negotiate or in the descriptive document</AC_CRITERION>
                  <AC_WEIGHTING>N/A</AC_WEIGHTING>
               </AC_COST>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>This Framework Agreement has the option to extend up to a period of 13 months.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="3">
               <TITLE>
                  <P>Wave 11 — Hospital Only Products: NWLN</P>
               </TITLE>
               <LOT_NO>03</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <MAIN_SITE>
                  <P>Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>NHS National Generic Pharmaceuticals — Wave 11.</P>
                  <P>Offer Reference Number: CM/PHG/17/5530.</P>
                  <P>Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 26 months.</P>
                  <P>Potential period of call-off under the Framework Agreement: Hospital Only Products:</P>
                  <P>NWLN 1.7.2018 to 31.7.2019 (13 months).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Price is not the only award criterion and all criteria are stated only in the procurement documents</AC_CRITERION>
                  <AC_WEIGHTING>In descending order</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>The Most Economically Advantageous Tender in terms of the criteria stated in the specification, in the Invitation to Tender or to negotiate or in the descriptive document</AC_CRITERION>
                  <AC_WEIGHTING>N/A</AC_WEIGHTING>
               </AC_COST>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>This Framework Agreement has the option to extend for up to a period of 13 months.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
            <OBJECT_DESCR ITEM="4">
               <TITLE>
                  <P>Wave 11 — Hospital Only Products — LSNE</P>
               </TITLE>
               <LOT_NO>04</LOT_NO>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33690000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="UK"/>
               <MAIN_SITE>
                  <P>Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>NHS National Generic Pharmaceuticals — Wave 11.</P>
                  <P>Offer Reference Number: CM/PHG/17/5530.</P>
                  <P>Period of Framework Agreement: dates detailed below with options to extend to a maximum period of 26 months.</P>
                  <P>Potential period of call-off under the Framework Agreement: Hospital Only Products:</P>
                  <P>LSNE 1.7.2018 to 31.7.2019 (13 months).</P>
               </SHORT_DESCR>
               <AC_QUALITY>
                  <AC_CRITERION>Price is not the only award criterion and all criteria are stated only in the procurement documents</AC_CRITERION>
                  <AC_WEIGHTING>In descending order</AC_WEIGHTING>
               </AC_QUALITY>
               <AC_COST>
                  <AC_CRITERION>The Most Economically Advantageous Tender in terms of the criteria stated in the specification, in the Invitation to Tender or to negotiate or in the descriptive document</AC_CRITERION>
                  <AC_WEIGHTING>N/A</AC_WEIGHTING>
               </AC_COST>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>This Framework Agreement has the option to extend for a period of up to 13 months.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 188-384724</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <CONTRACT_NO>CM/PHG/17/5530</CONTRACT_NO>
            <LOT_NO>01</LOT_NO>
            <TITLE>
               <P>Wave 11 — Oral Products: All regions</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>107</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>59</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_EMEANS>107</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Please see list of awarded suppliers (including SME status) at the following website: https://www.gov.uk/contracts-finder</OFFICIALNAME>
                     <TOWN>Please see list of awarded suppliers (including SME status) at the following website: https://www.go</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">14000000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="2">
            <CONTRACT_NO>CM/PHG/17/5530</CONTRACT_NO>
            <LOT_NO>02</LOT_NO>
            <TITLE>
               <P>Wave 11 — Hospital Only Products: CESW</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>107</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>59</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_EMEANS>107</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Please see list of awarded suppliers (including SME status) at the following website: https://www.gov.uk/contracts-finder</OFFICIALNAME>
                     <TOWN>Please see list of awarded suppliers (including SME status) at the following website: https://www.go</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">154000000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="3">
            <CONTRACT_NO>CM/PHG/17/5530</CONTRACT_NO>
            <LOT_NO>03</LOT_NO>
            <TITLE>
               <P>Wave 11 — Hospital Only Products: NWLN</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>107</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>59</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_EMEANS>107</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Please see list of awarded suppliers (including SME status) at the following website: https://www.gov.uk/contracts-finder</OFFICIALNAME>
                     <TOWN>Please see list of awarded suppliers (including SME status) at the following website: https://www.go</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">148000000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <AWARD_CONTRACT ITEM="4">
            <CONTRACT_NO>CM/PHG/17/5530</CONTRACT_NO>
            <LOT_NO>04</LOT_NO>
            <TITLE>
               <P>Wave 11 — Hospital Only Products: LSNE</P>
            </TITLE>
            <AWARDED_CONTRACT>
               <DATE_CONCLUSION_CONTRACT>2018-03-21</DATE_CONCLUSION_CONTRACT>
               <NB_TENDERS_RECEIVED>107</NB_TENDERS_RECEIVED>
               <NB_TENDERS_RECEIVED_SME>59</NB_TENDERS_RECEIVED_SME>
               <NB_TENDERS_RECEIVED_EMEANS>107</NB_TENDERS_RECEIVED_EMEANS>
               <NO_AWARDED_TO_GROUP/>
               <CONTRACTOR>
                  <ADDRESS_CONTRACTOR>
                     <OFFICIALNAME>Please see list of awarded suppliers (including SME status) at the following website: https://www.gov.uk/contracts-finder</OFFICIALNAME>
                     <TOWN>Please see list of awarded suppliers (including SME status) at the following website: https://www.go</TOWN>
                     <COUNTRY VALUE="UK"/>
                     <n2016:NUTS CODE="UK"/>
                  </ADDRESS_CONTRACTOR>
                  <SME/>
               </CONTRACTOR>
               <VAL_TOTAL CURRENCY="GBP">118000000</VAL_TOTAL>
            </AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Please see list of awarded suppliers (Including SME status) at the following website:</P>
               <P>https://www.gov.uk/contracts-finder</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The NHS Commissioning Board (Operating Under the Name of NHS England)</OFFICIALNAME>
               <TOWN>Runcorn</TOWN>
               <COUNTRY VALUE="UK"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-04-10</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
